Dysphagia predict the response to second cycle neoadjuvant chemotherapy in first cycle no response esophageal carcinoma

BACKGROUND: After the first-cycle of neoadjuvant chemotherapy (NAC), many patients with esophageal squamous cell carcinoma (ESCC) experience a stable disease (SD)/progressive disease (PD) response. Clinically, SD patients are recommended to receive a second cycle of NAC, and PD patients are recommen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Zheng, Yan, Li, Yin, Qin, Jianjun, Xing, Wenqun, Liu, Xianben, Sun, Haibo, Chen, Xiankai
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6837951/
https://ncbi.nlm.nih.gov/pubmed/31737296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.10.02
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados